johnson Johnson & Johnson to contribute up to $5B US in potential settlements over its part in U.S. opioid crisis Company denies wrongdoing, is separately appealing a judgment the state of Oklahoma won against it. Johnson & Johnson said Tuesday it would contribute up to $1 billion US more to a potential settlement of lawsuits alleging it and other companies fuelled the U.S. opioid crisis. That contribution would bring the total amount the New Brunswick, N.J.-based drug manufacturer would pay to $5 billion ($6.57 billion CDN). The additional money represents an increase to a proposed $4 billion settlement framework Johnson & Johnson (J&J) negotiated with a group of state attorneys general that was announced last year, the company said.

McKinsey Consultancy McKinsey agrees to pay nearly $600M for role in opioid crisis Company worked with Purdue Pharma to boost sales even as the extent of the opioid epidemic became clear